-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Amgen, Raises Price Target to $480

Benzinga·10/23/2026 17:03:20
Listen to the news
Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $450 to $480.